• Wilfried W H Roeloffzen, Hanneke C Kluin-Nelemans, Andre B Mulder, Nic J G M Veeger, Lotte Bosman, and Joost Th M de Wolf.
• Department of Hematology, University Medical Center Groningen, Groningen 9700 RB, The Netherlands. j.t.m.de.wolf@int.umcg.nl
• Anesth. Analg. 2010 Apr 1; 110 (4): 987-94.

BackgroundOur objective was to analyze the effects of age, gender, and the use of oral contraceptives (OCs) on coagulation using thrombelastography (TEG), a single test to analyze both plasma coagulation factors and cellular elements in whole blood.MethodsTEG variables were measured in native whole blood and in recalcified citrated blood from 120 healthy adults (60 men and 60 women) with various ages and in an additional 29 healthy women using OCs.ResultsWe observed hypercoagulability in women compared with men and in women using OCs compared with age-matched nonusers. Moreover, we found hypercoagulability with aging. Using the method of Bland and Altman (Lancet 1986;1:307-10), we demonstrated no correlation between TEG measurements in native and recalcified citrated blood.ConclusionsAging, female gender, use of OCs, and low-normal hematocrit levels have significant procoagulant effects. TEG measurements in native and recalcified citrated blood are not interchangeable, as indicated by differences between the 2 measurements ranging from 20% in maximal amplitude to 246% in clotting time. Furthermore, the limits of agreement strongly exceeded clinical acceptability to conclude interchangeability.

28 keywords...

hide…